Catherine Raptopoulou

Dr. Catherine Raptopoulou

Institute of Nanoscience and Nanotechnology, NCSR "demokritos", Athens, Greece
orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2021 in Materials
Verified
Journal Article
Open access
PDF file
Catherine RaptopoulouCatherine Raptopoulou
Catherine Raptopoulou
Metal-organic frameworks represent a porous class of materials that are build up from metal ions or oligonuclear metallic complexes and organic ligands. They can be considered as sub-class of coordination polymers and can be extended into one-dimension, two-dimensions, and three-dimensions. Depending on the size of the pores, MOFs are divided into nanoporous, mesoporous, and macroporous items. The latter two are usually amorphous. MOFs display high porosity, a large specific surface area, and high thermal stability due to the presence of coordination bonds. The pores can incorporate neutral molecules, such as solvent molecules, anions, and cations, depending on the overall charge of the MOF, gas molecules, and biomolecules. The structural diversity of the framework and the multifunctionality of the pores render this class of materials as candidates for a plethora of environmental and biomedical applications and also as catalysts, sensors, piezo/ferroelectric, thermoelectric, and magnetic materials. In the present review, the synthetic methods reported in the literature for preparing MOFs and their derived materials, and their potential applications in environment, energy, and biomedicine are discussed.

19 December 2003 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
CMConstantinos J. Milios
Constantinos J. Milios
Catherine RaptopoulouCatherine Raptopoulou
Catherine Raptopoulou
ATAris Terzis
Aris Terzis
FLFrancesc Lloret
Francesc Lloret
RVRamon Vicente
Ramon Vicente
AEAlbert Escuer
Albert Escuer

6 April 2010 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
FDFilitsa Dimiza
Filitsa Dimiza
APAthanasios N. Papadopoulos
Athanasios N. Papadopoulos
Vassilis TangoulisVassilis Tangoulis
Vassilis Tangoulis
Vassilis PsycharisVassilis Psycharis
Vassilis Psycharis
Catherine RaptopoulouCatherine Raptopoulou
Catherine Raptopoulou
GPGeorge Psomas
George Psomas
Cobalt(II) complexes with the non-steroidal anti-inflammatory drug mefenamic acid in the presence or absence of nitrogen donor heterocyclic ligands (2,2′-bipyridine, 1,10-phenanthroline or pyridine) have been synthesized and characterized with physicochemical and spectroscopic techniques. The experimental data suggest that mefenamic acid acts as deprotonated monodentate ligand coordinated to Co(II) ion through a carboxylato oxygen. The crystal structures of tetrakis(methanol)bis(mefenamato)cobalt(II), 1 and (2,2′-bipyridine)bis(methanol)bis(mefenamato)cobalt(II), 2 have been determined by X-ray crystallography. The EPR spectra of complexes 1 and 2 in frozen solution reveal that they retain their structures. UV study of the interaction of the complexes with calf-thymus DNA (CT DNA) has shown that the complexes can bind to CT DNA and bis(methanol)bis(pyridine)bis(mefenamato)cobalt(II) exhibits the highest binding constant. Competitive study with ethidium bromide (EB) has shown that the complexes can displace the DNA-bound EB indicating that they bind to DNA in strong competition with EB. The cyclic voltammograms of the complexes recorded in dmso solution and in the presence of CT DNA in 1 : 2 dmso : buffer (containing 150 mM NaCl and 15 mM trisodium citrate at pH 7.0) solution have shown that they can bind to CT DNA by the intercalative binding mode. Mefenamic acid and its cobalt(II) complexes exhibit good binding propensity to human or bovine serum albumin protein having relatively high binding constant values. The antioxidant activity of the compounds has been evaluated indicating their high scavenging activity against hydroxyl free radicals and superoxide radicals.

1 August 2011 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
FDFilitsa Dimiza
Filitsa Dimiza
SFStella Fountoulaki
Stella Fountoulaki
APAthanasios N. Papadopoulos
Athanasios N. Papadopoulos
CKChristos A. Kontogiorgis
Christos A. Kontogiorgis
Vassilis TangoulisVassilis Tangoulis
Vassilis Tangoulis
GPGeorge Psomas
George Psomas
Copper(II) complexes with the non-steroidal antiinflammatory drug mefenamic acid in the presence of aqua or nitrogen donor heterocyclic ligands (2,2′-bipyridine, 1,10-phenanthroline, 2,2′-bipyridylamine or pyridine) have been synthesized and characterized. The crystal structures of [(2,2′-bipyridine)bis(mefenamato)copper(II)], 2, [(2,2′-bipyridylamine)bis(mefenamato)copper(II)], 4, and [bis(pyridine)bis(methanol)bis(mefenamato)copper(II)], 5, have been determined by X-ray crystallography. UV study of the interaction of the complexes with calf-thymus DNA (CT DNA) has shown that the complexes can bind to CT DNA and [bis(aqua)tetrakis(mefenamato)dicopper(II)] exhibits the highest binding constant to CT DNA. The cyclic voltammograms of the complexes in the presence of CT DNA solution have shown that the complexes can bind to CT DNA by the intercalative binding mode verified also by DNA solution viscosity measurements. Competitive studies with ethidium bromide (EB) indicate that the complexes can displace the DNA-bound EB suggesting strong competition with EB. Mefenamic acid and its complexes exhibit good binding propensity to human or bovine serum albumin protein having relatively high binding constant values. All the compounds have been tested for their antioxidant and free radical scavenging activity as well as for their in vitro inhibitory activity against soybean lipoxygenase showing significant activity.

10 July 2007 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
Theocharis C StamatatosTheocharis C Stamatatos
Theocharis C Stamatatos
DFDolos Foguet-Albiol
Dolos Foguet-Albiol
SLSheng-Chiang Lee
Sheng-Chiang Lee
CSConstantinos C. Stoumpos
Constantinos C. Stoumpos
Catherine RaptopoulouCatherine Raptopoulou
Catherine Raptopoulou
GCGeorge Christou
George Christou

1 September 1995 in Inorganic Chemistry
Verified
Journal Article
Closed access
APAthanassios Panagiotopoulos
Athanassios Panagiotopoulos
TZTheodoros F. Zafiropoulos
Theodoros F. Zafiropoulos
SPSpyros P. Perlepes
Spyros P. Perlepes
EBEvangelos Bakalbassis
Evangelos Bakalbassis
IMIsabelle Masson-Ramade
Isabelle Masson-Ramade
Catherine RaptopoulouCatherine Raptopoulou
Catherine Raptopoulou